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Abstract It has been reported that expression of the active
mutant of heterotrimeric GTP-binding protein K subunit GKi2
transforms Rat-1 cells. However, the GKi2-mediated mitogenic
signaling pathways remain to be elucidated. Here, we demon-
strate that inducible expression of the active mutant of GKi2
(GKi2(Q205L)) activates Ras and c-Jun N-terminal kinase
(JNK) in addition to extracellular signal-regulated kinase (ERK)
in Rat-1 cells. Our findings suggest that Ras may play a critical
role in the GKi2-induced transformation and GKi2 can transduce
signals from the Gi-coupled receptor to JNK and ERK in certain
types of mammalian cells.
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Key words: G protein; gip2 ; Ras; c-Jun N-terminal kinase;
Transformation; Inducible expression system
1. Introduction
Heterotrimeric GTP-binding proteins (G proteins) play key
roles in the intracellular signal transductions from the cell
surface receptors which possess seven transmembrane do-
mains. The K subunit of G proteins (GK) has a guanine nu-
cleotide-binding site and an intrinsic GTPase activity. The
GDP-bound GK forms a complex with G protein LQ subunits
(GLQ). When the receptors are activated by stimuli, the acti-
vated receptors induce the exchange of the guanine nucleotide
from GDP to GTP on GK, and the GKLQ heterotrimer dis-
sociates into the GTP-bound GK and the GLQ heterodimer.
The GTP-bound GK can interact with the e¡ectors, such as
adenylyl cyclase, phospholipase (PLC) L, and cGMP phos-
phodiesterase. GLQ can also interact with and regulate the
e¡ectors, such as certain types of adenylyl cyclases, PLC L
and G protein-coupled inwardly rectifying K channel
(GIRK) [1,2]. In addition, it was reported that GLQ can acti-
vate Ras-regulated mitogenic signaling cascades [3^6].
In certain human tumor cells, GTPase-de¢cient mutations
of GK which form a constitutively active form have been
found. Mutation of the GKs gene (designated gsp oncogene)
was found in pituitary tumors and thyroid adenomas [7,8].
The gsp product constitutively activates adenylyl cyclase and
elevates the intracellular cAMP level. Mutation of the GKi2
gene (designated gip2 oncogene) was found in tumors of adre-
nal cortex and ovary [8]. The gip2 product inhibits cAMP
accumulation [9]. Expression of the mutant GKi2 in Rat-1
cells induces transformation [10,11].
To clarify the mechanism of the GKi2-mediated cell prolif-
eration, several groups have investigated intracellular mito-
genic signals and transcriptional regulation of immediate early
genes. In Rat-1 cells expressing the constitutively active GKi2,
extracellular signal-regulated kinase (ERK) and its activator,
MAPK/ERK kinases (MEK), are activated [12]. Microinjec-
tion of the antibody that interferes with the function of GKi2
inhibits the lysophosphatidic acid (LPA)-induced activation of
c-fos promoter in mouse ¢broblasts [13]. In addition, trans-
fection of the constitutively active GKi2 activates c-fos pro-
moter in CHO and Rat-1 cells [14], and enhances the activity
of the collagenase promoter which is regulated by AP-1 in a
c-Jun-dependent manner in Rat-1 cells [15]. However, the ac-
tivation of molecules upstream of MEK and c-Jun, such as
Ras and c-Jun N-terminal kinase (JNK), has not yet been
investigated.
To study the mitogenic signals mediated by GKi2, we con-
structed a Rat-1 transfectant expressing an oncogenic mutant
of GKi2 (GKi2(Q205L)) in an isopropyl-1-L-thio-D-galactoside
(IPTG)-dependent manner. In this transfectant, Ras was acti-
vated by expression of GKi2(Q205L). Moreover, activation of
JNK as well as ERK was found.
2. Materials and methods
2.1. Plasmids
A plasmid pEF-LAC-Gi2(Q205L) was constructed by insertion of
cDNA of rat GKi2 [16] whose glutamine-205 was substituted for leu-
cine into the NotI site of pEF-LAC [17]. A plasmid pOPRSVI-
Ras(V12) was constructed by insertion of cDNA of c-Ha-Ras whose
glycine-12 was substituted for valine [18] into the NotI site of pOPRS-
VI (Stratagene). A lactose repressor expression vector p3PSS was ob-
tained from Stratagene. An expression vector for wild type c-Ha-Ras,
pCMV5-Ras(WT) [6], was obtained from T. Satoh.
2.2. Glutathione S-transferase (GST) fusion protein
GST-fused c-Jun (1^223) was produced as described elsewhere [19].
GST-fused c-Raf-1 Ras-binding domain (GST-RBD) produced in Es-
cherichia coli was provided by K. Tago.
2.3. Cell culture and stable transfectants
Rat embryonic ¢broblast Rat-1 cells were grown in Dulbecco’s
modi¢ed Eagle’s (DME) medium supplemented with 10% fetal calf
serum (FCS). Rat-1 cells were transfected with 4 Wg of pEF-LAC-
Gi2(Q205L) and 16 Wg of p3PSS (for Rat-1WQL112), or 10 Wg of
pOPRSVI-Ras(V12) and 10 Wg of p3PSS (for Rat-1WRasValA1) by
the calcium phosphate coprecipitation technique. Stable transfectants
were selected with 1 mg/ml G418 and 0.4 mg/ml hygromycin B.
2.4. Analysis of the protein expression
Membrane proteins were analyzed by immunoblotting using a rab-
bit anti-GKi1/2 antibody (AS/7, NEN Life Science). To detect
GKi2(Q205L), a trypsin resistance assay was performed. Membrane
proteins (20 Wg) were solubilized in 8 Wl of bu¡er (20 mM HEPES-
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NaOH (pH 8.0), 10 mM MgCl2, 1 mM EDTA, 1 mM DTT, 0.64%
(w/v) Luburol PX). After the solubilized proteins were incubated with
111 WM GTP at 30‡C for 30 min, TPCK-treated trypsin (Sigma) was
added (200 Wg/ml) and incubated at 30‡C for 5 min. The reactions
were terminated by adding trypsin-chymotrypsin inhibitor (2.2 mg/ml,
Sigma) and Laemmli sample bu¡er. The samples were analyzed by
immunoblotting.
2.5. Colony formation in soft agar
Cells (3U104 cells) were seeded into 60-mm dishes with DME me-
dium supplemented with 0.27% agar and 10% FCS over the DME
medium containing 0.53% agar and 10% FCS. After the cells were
cultured for 12 days in the absence or presence of 5 mM IPTG,
microphotographs were taken.
2.6. Analysis of RasWGTP
The Ras-bound guanine nucleotide was analyzed as described pre-
viously [6,20]. An assay for RasWGTP by determining the association
between RasWGTP and Ras-binding domain of c-Raf-1 in vitro was
performed as described elsewhere [21] with minor modi¢cations. In
brief, cells were transfected with 5 Wg of pCMV5-Ras(WT) using
Lipofectamine (Gibco BRL). After transfection, the cells were in-
cubated with or without 5 mM IPTG for 24 h in the absence of
serum. After stimulation with agonists, the cells were harvested and
lysed with RasWGTP IP bu¡er (50 mM Tris-HCl (pH 7.5), 20 mM
MgCl2, 150 mM NaCl, 0.5% Nonidet P-40, 20 Wg/ml aprotinin, 1 mM
Na3VO4). RasWGTP associated with GST-RBD was collected with
glutathione-Sepharose 4B beads (Amersham-Pharmacia) and analyzed
by immunoblotting with an anti-Ha-Ras antibody (sc-520, Santa Cruz
Biotechnology).
2.7. ERK2 and JNK1 assays
The kinase activity of ERK2 or JNK1 was assessed by in vitro
kinase assay as described previously [19,22,23]. Phosphorylation of
ERK2 was assayed by electrophoretic mobility shift using a mouse
anti-ERK2 antibody (05-157, Upstate Biotechnology) as described
previously [6].
3. Results
3.1. IPTG-induced expression of GKi2(Q205L) in Rat-1
transfectants
To explore the function of GKi2 on the mitogenic signaling
pathways, we constructed Rat-1 transfectants which express
GKi2(Q205L) inducibly with IPTG treatment. Immunoblot
analysis using an antibody for GKi suggested that the
IPTG-dependent expression of the exogenous GKi2(Q205L)
is comparable to that of endogenous GKi (Fig. 1a). It has
been reported that the GTP-bound form of GK is substan-
tially protected from tryptic proteolysis [24]. To con¢rm the
expression of GKi2(Q205L), tryptic proteolysis of GKi was
performed. The exogenous GKi2(Q205L) was cleaved into
two fragments (of 2 and 38 kDa) by trypsin, whereas the
endogenous wild type GKi was completely digested under
the same conditions. The 38-kDa tryptic fragment of GKi
was detected by the anti-GKi antibody for the C-terminus
region of GKi protein. Fig. 1b shows that GKi2(Q205L) was
accumulated in one transfectant, designated Rat-1WQL112.
Another type of Rat-1 transfectant, designated Rat-1WRasVal-
A1, was also prepared. In this transfectant, constitutively
active mutant Ras (Ras(G12V)) was accumulated after
IPTG treatment (data not shown).
3.2. Colony formation of Rat-1 transfectants in soft agar
It has been reported that transfection of the mutationally
activated GKi2 mutants (R179C, R179H, and Q205L) induces
anchorage-independent growth of Rat-1 cells [10,11]. To test
the transforming activity of the inducibly expressed
GKi2(Q205L), colony formation in soft agar was assayed.
Parental Rat-1 cells and their transfectants, Rat-1WQL112
and Rat-1WRasValA1, were seeded into soft agar and treated
with IPTG. The parental cells did not form any marked col-
onies in the soft agar (Fig. 2a,b). On the other hand, IPTG
treatment induced the colony formation of Rat-1WQL112 cells
(Fig. 2c,d). However, the size of colonies of Rat-1WQL112 was
smaller than that of Rat-1WRasValA1 (Fig. 2d,f). This experi-
ment shows that, in Rat-1WQL112 cells, inducibly expressed
GKi2(Q205L) has transforming activity and elicits certain mi-
togenic signals.
3.3. Ras activation in GKi2(Q205L)-expressed Rat-1 cells
Ras is activated by various growth factors, cytokines,
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Fig. 1. IPTG-induced expression of GKi2(Q205L) in the Rat-1
transfectant. a: Immunoblot analysis of the crude membrane of
Rat-1WQL112 cells. The cells were treated with 5 mM IPTG for the
indicated hours and the membrane protein was immunoblotted with
an anti-GKi antibody (AS/7). b: Tryptic proteolysis of GKi. The
membrane proteins were treated with trypsin as described in Section
2. The 38-kDa tryptic fragment was detected with AS/7 antibody.
Fig. 2. Anchorage-independent growth of Rat-1 transfectants in soft
agar. Parental Rat-1 (a and b), Rat-1WQL112 (c and d), and Rat-
1WRasValA1 (e and f) cells were seeded in 0.27% soft agar over
0.53% bottom agar without (a, c, and e) or with 5 mM IPTG (b, d,
and f). Microphotographs were taken after culture for 12 days.
H. Edamatsu et al./FEBS Letters 440 (1998) 231^234232
and certain types of G protein-coupled receptor agonists, and
plays a key role in mitogenic signaling cascades [1,25].
To evaluate the activity of Ras in GKi2(Q205L)-expressed
Rat-1 cells, Ras-bound guanine nucleotide was assayed.
Rat-1WQL112 cells were labeled with 32P, and treated with
IPTG in serum-free medium. Ras was immunoprecipitated,
and the bound guanine nucleotide was analyzed. As shown
in Fig. 3a, the ratio of GTP versus GTP+GDP in the anti-Ras
immunoprecipitate was increased after the cells were treated
with IPTG for 24 h, or stimulated with epidermal growth
factor (EGF) for 5 min. To con¢rm the Ras activation by
expression of GKi2(Q205L), the association of RasWGTP
with the Ras-binding domain (RBD) of c-Raf-1 was analyzed
[21]. Since the expression level of endogenous Ras is very low,
exogenous Ha-Ras was transfected into Rat-1WQL112 cells. A
small amount of RasWGTP from serum-deprived control cells
was precipitated with GST-RBD in vitro (Fig. 3b). Treatment
of the cells with EGF or LPA increased the complex forma-
tion of Ras and GST-RBD (Fig. 3b). In addition, IPTG treat-
ment increased the amount of Ras precipitated from the ly-
sates of Rat-1WQL112 cells (Fig. 3b), but not of parental Rat-1
cells (data not shown). These results indicate that Ras is acti-
vated in the GKi2(Q205L)-expressed Rat-1 cells.
3.4. Activation of JNK1 in GKi2(Q205L)-expressed Rat-1 cells
It has been reported that constitutive activation of Ras
induces the activation of JNK [26]. In Rat-1WRasValA1 cells,
IPTG treatment stimulated JNK1 activity (data not shown).
To investigate whether the expression of GKi2(Q205L) in Rat-1
cells induces JNK activation, an in vitro kinase assay was
performed. Rat-1WQL112 cells were starved of serum and
treated with or without IPTG. Then, JNK1 was immunopre-
cipitated from the cell lysate, and in vitro kinase activity was
assayed. As shown in Fig. 4a, JNK1 activity was enhanced in
IPTG-treated Rat-1WQL112 cells. ERK2 was also activated as
reported previously [12] (Fig. 4b). Moreover, phosphorylation
of ERK2 was detected 12 h after IPTG treatment (Fig. 4c). It
was suggested that long-term activation of an ERK cascade
might induce JNK activation through secretion of an extra-
cellular mediator [26]. A recent study showed that activation
of the ERK cascade induces JNK activation through the in-
duction of heparin-binding epidermal growth factor (HB-
EGF) [27]. To examine the possibility of ERK-dependent
JNK activation, Rat-1WQL112 cells were treated with a
MEK1 inhibitor, PD98059 [28^30]. Fig. 4 shows that
GKi2(Q205L)-induced JNK1 activation was not inhibited by
PD98059, whereas ERK2 activation was completely inhibited.
These results indicate that the active GKi2 activates JNK1 in
an ERK-independent manner.
4. Discussion
In this study, we show that expression of the constitutively
active mutant of GKi2 induces activation of Ras in Rat-1
cells. This result suggests that Ras may be a key molecule in
the GKi2-mediated mitogenic signaling pathways. However,
the mechanism of Ras activation by GKi2 remains to be elu-
cidated. Ras activation is regulated by the activation of Ras-
guanine nucleotide exchanging factors (GEF) and/or the in-
hibition of Ras-GTPase activating proteins (GAP). It has
been reported that oncogenic GKi2-induced transformation
of Rat-1 cells was not inhibited by the expression of domi-
nant-negative Ras (Ras(S17N)) which inhibits Ras activation
by trapping GEFs in an inactive complex [11]. In neutrophils,
f-Met-Leu-Phe (FMLP)-induced Ras activation is associated
with inhibition of p120-GAP activity [31]. These results sug-
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Fig. 4. Activation of JNK1 and ERK2 in the GKi2(Q205L)-ex-
pressed cells. Rat-1WQL112 cells were starved of serum, and treated
with 5 mM IPTG in the presence or absence of 50 WM PD98059
for 36 h. In vitro kinase activity of JNK1 (a) and ERK2 (b) was as-
sayed. The results are shown as the mean þ S.E.M. from three inde-
pendent experiments. c: ERK2 phosphorylation by expression of
GKi2(Q205L). Rat-1WQL112 cells were treated with 5 mM IPTG for
the indicated hours. The phosphorylated ERK2 (pERK2) was de-
tected by immunoblotting using an anti-ERK2 antibody.
Fig. 3. IPTG-induced increase of GTP-bound Ras in Rat-1WQL112.
a: Increase of Ras-bound GTP in Rat-1WQL112 cells. Con£uent cul-
ture of Rat-1WQL112 cells was starved of serum and labeled with
32P. The cells were treated with 5 mM IPTG for 24 h, or stimulated
with 100 ng/ml EGF for 5 min. The RasWGTP (%) was determined
(GTP/(GDP+GTP) (%)). The bars show the mean þ S.E.M. of three
to ¢ve independent experiments. An asterisk indicates P6 0.01 as
compared with the control. b: In vitro association of RasWGTP with
c-Raf-RBD. Rat-1WQL112 cells were transfected with pCMV5-
Ras(WT), and starved of serum. The cells were treated with 5 mM
IPTG for 24 h, or stimulated with 100 ng/ml EGF or 100 WM LPA
for 5 min. RasWGTP associated with c-Raf-RBD (GST-RBD) was
analyzed by immunoblotting with an anti-Ha-Ras antibody.
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gest that GKi2-induced Ras activation might be mediated by
the inhibition of GAPs rather than by the activation of GEFs.
In Rat-1WQL112 cells, JNK1, as well as ERK2, was acti-
vated by induction of GKi2(Q205L) (Fig. 4). It was previously
reported that the long-term activation of Raf and ERK re-
sulted in the activation of JNK through secretion of HB-EGF
[27]. However, the JNK1 activation was not inhibited by the
MEK1 inhibitor PD98059 (Fig. 4a), whereas ERK2 activation
was completely inhibited (Fig. 4b). The culture supernatant
from the IPTG-treated Rat-1WQL112 cells had no activity to
induce JNK1 activation, whereas the culture supernatant from
the IPTG-treated Rat-1WRasValA1 induced JNK1 activation
(data not shown). These results indicate that GKi2-induced
JNK1 activation is independent of ERK2 activation. It was
previously reported that, in Rat-1 cells, GKi2-induced activa-
tion of collagenase promoter which contains AP-1-binding
sites was c-Jun-dependent [15]. Our results suggest that this
AP-1 activation may be mediated by the GKi2-induced acti-
vation of JNK1. Recent studies have shown that Jun activity
is essential for the transformation induced by oncoproteins,
such as Ras and Bcr-Abl [32,33]. Hence, activation of JNK, as
well as activation of ERK, may be critical for the induction of
the transformation of Rat-1 cells by constitutively active
GKi2.
The present results obtained from the IPTG-induced ex-
pression of GKi2 revealed that Ras and JNK1 are activated
in GKi2-transformed Rat-1 cells. It was suggested that GKi2,
in addition to GLQ, may activate Ras-mediated signaling cas-
cades upon receptor activation. The activation of Ras and
JNK1 may be cell type-dependent. Indeed, gip2 mutations
have been detected only in tumors of adrenal cortex and ova-
ry [8], whereas ras mutations have been detected in various
types of human tumors. Clari¢cation of the mechanism of
GKi2-mediated regulation of Ras activity should provide im-
portant ¢ndings that explain tumors induced by gip2 muta-
tions and cell proliferation regulated by GKi2.
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